DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DBVT DBV Technologies S.A.

已收盘 11-18 16:00:00 EST

0.5100

-0.0798

-13.53%

盘后0.5309

+0.0209+4.10%

19:48 EST

最高0.5999	最低0.5079	成交量10.39万
今开0.5898	昨收0.5898	日振幅15.60%
总市值4,922万	流通市值2,159万	总股本9,650万
成交额5.82万	换手率0.25%	流通股本4,233万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"DBVT","market":"US","secType":"STK","nameCN":"DBV Technologies S.A.","latestPrice":0.51,"timestamp":1731963600000,"preClose":0.5898,"halted":0,"volume":103935,"hourTrading":{"tag":"盘后","latestPrice":0.5309,"preClose":0.51,"latestTime":"19:48 EST","volume":169,"amount":91.1169,"timestamp":1731977322418},"delay":0,"floatShares":42331967,"shares":96501526,"eps":-1.061645,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.0798,"latestTime":"11-18 16:00:00 EST","open":0.5898,"high":0.5999,"low":0.5079,"amount":58217.05958249999,"amplitude":0.155985,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.061645,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":1,"listingDate":1413950400000,"adjPreClose":0.5898,"adrRate":1,"postHourTrading":{"tag":"盘后","latestPrice":0.5309,"preClose":0.51,"latestTime":"19:48 EST","volume":169,"amount":91.1169,"timestamp":1731977322418},"volumeRatio":1.341242,"impliedVol":4.0465,"impliedVolPercentile":0.9928},"requestUrl":"/m/hq/s/DBVT","defaultTab":"news","newsList":[{"id":"2484607615","title":"Dbv Technologies盘中异动 股价大跌6.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484607615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484607615?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:59","pubTimestamp":1731956354,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时59分，Dbv Technologies股票出现波动，股价大幅下挫6.75%。截至发稿，该股报0.550美元/股，成交量5.0747万股，换手率0.05%，振幅8.34%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.01%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119025914971a741f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119025914971a741f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2483370171","title":"Dbv Technologies盘中异动 股价大涨8.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483370171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483370171?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:32","pubTimestamp":1731681171,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时32分，Dbv Technologies股票出现波动，股价大幅拉升8.75%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为1.15%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522325195be3471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522325195be3471&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2483331659","title":"Dbv Technologies盘中异动 大幅跳水5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483331659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483331659?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:18","pubTimestamp":1731615489,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时18分，Dbv Technologies股票出现异动，股价大幅下跌5.47%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为1.35%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115041810971a6a1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115041810971a6a1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2483844030","title":"Dbv Technologies盘中异动 股价大跌5.17%报0.640美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483844030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483844030?lang=zh_cn&edition=full","pubTime":"2024-11-13 02:33","pubTimestamp":1731436433,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日02时33分，Dbv Technologies股票出现波动，股价急速下挫5.17%。截至发稿，该股报0.640美元/股，成交量8.243万股，换手率0.09%，振幅5.35%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.79%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111302335398e42285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111302335398e42285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2482735807","title":"Dbv Technologies盘中异动 快速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482735807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482735807?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:32","pubTimestamp":1731335561,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时32分，Dbv Technologies股票出现波动，股价大幅拉升5.19%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.13%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122324195be107f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122324195be107f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2482359466","title":"Dbv Technologies2024财年第三财季实现净利润-30.44百万美元，同比减少81.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482359466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482359466?lang=zh_cn&edition=full","pubTime":"2024-11-09 08:01","pubTimestamp":1731110509,"startTime":"0","endTime":"0","summary":"11月9日，Dbv Technologies公布财报，公告显示公司2024财年第三财季净利润为-30.44百万美元，同比减少81.84%；其中营业收入为0.00美元，每股基本收益为-0.32美元。从资产负债表来看，Dbv Technologies总负债39.02百万美元，其中短期债务7.95百万美元，资产负债比为2.39，流动比率为2.23。机构评级：截至2024年11月9日，当前有4家机构对Dbv Technologies目标价做出预测，其中目标均价为4.71美元，其中最低目标价为2.74美元，最高目标价为7.00美元。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109080152abaf32be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109080152abaf32be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT"],"gpt_icon":0},{"id":"2481488453","title":"Dbv Technologies盘中异动 早盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481488453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481488453?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:36","pubTimestamp":1731080165,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时36分，Dbv Technologies股票出现异动，股价急速下跌5.15%。截至发稿，该股报0.701美元/股，成交量2.1054万股，换手率0.02%，振幅2.67%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.96%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823360598e41848&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823360598e41848&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2481184881","title":"Dbv Technologies盘中异动 股价大跌5.18%报0.730美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481184881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481184881?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:04","pubTimestamp":1730991881,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时04分，Dbv Technologies股票出现异动，股价急速下挫5.18%。截至发稿，该股报0.730美元/股，成交量1.9251万股，换手率0.02%，振幅1.43%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.03%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723044198e41392&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723044198e41392&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2480584280","title":"Dbv Technologies盘中异动 急速上涨5.08%报0.800美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480584280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480584280?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:00","pubTimestamp":1730732433,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时00分，Dbv Technologies股票出现异动，股价急速拉升5.08%。截至发稿，该股报0.800美元/股，成交量7.6271万股，换手率0.08%，振幅2.98%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.02%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110423003398e404d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110423003398e404d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2479603707","title":"Dbv Technologies盘中异动 急速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479603707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479603707?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:34","pubTimestamp":1730388847,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时34分，Dbv Technologies股票出现波动，股价急速下挫5.10%。截至发稿，该股报0.762美元/股，成交量17.0575万股，换手率0.18%，振幅4.56%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为3.48%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031233407ab8c2561&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031233407ab8c2561&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2478481587","title":"Dbv Technologies盘中异动 早盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478481587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478481587?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:51","pubTimestamp":1730123481,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时51分，Dbv Technologies股票出现异动，股价急速跳水5.29%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.66%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215122971a2a7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215122971a2a7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2478763935","title":"Dbv Technologies盘中异动 大幅拉升5.41%报0.883美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478763935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478763935?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:02","pubTimestamp":1729864955,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时02分，Dbv Technologies股票出现波动，股价快速上涨5.41%。截至发稿，该股报0.883美元/股，成交量43.9442万股，换手率0.46%，振幅4.68%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.78%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025220235a1ea9819&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025220235a1ea9819&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","ELAB","BK4183","BK4139"],"gpt_icon":0},{"id":"2477963182","title":"Dbv Technologies股价飙升24.91% 市值涨2035.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477963182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477963182?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:32","pubTimestamp":1729776776,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时32分，Dbv Technologies股票出现异动，股价快速上涨24.91%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.38%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421325795bd4d9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421325795bd4d9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2477368234","title":"Dbv Technologies盘中异动 大幅下跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477368234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477368234?lang=zh_cn&edition=full","pubTime":"2024-10-23 00:39","pubTimestamp":1729615164,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日00时39分，Dbv Technologies股票出现异动，股价大幅下跌5.85%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为1.29%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023003925ab6c44f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023003925ab6c44f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2476946416","title":"Dbv Technologies盘中异动 大幅拉升6.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476946416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476946416?lang=zh_cn&edition=full","pubTime":"2024-10-17 00:23","pubTimestamp":1729095829,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日00时23分，Dbv Technologies股票出现波动，股价急速上涨6.41%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.40%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017002349a1e124d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017002349a1e124d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2475683580","title":"Dbv Technologies盘中异动 早盘股价大涨6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475683580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475683580?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:33","pubTimestamp":1728999239,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时33分，Dbv Technologies股票出现异动，股价快速上涨6.11%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.38%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101521335998e3c87a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101521335998e3c87a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2473479978","title":"Dbv Technologies盘中异动 早盘大幅上涨5.78%报0.719美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473479978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473479978?lang=zh_cn&edition=full","pubTime":"2024-10-08 22:39","pubTimestamp":1728398361,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日22时39分，Dbv Technologies股票出现波动，股价急速拉升5.78%。截至发稿，该股报0.719美元/股，成交量2.4306万股，换手率0.03%，振幅2.94%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.25%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008223922ab687f75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008223922ab687f75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2472644891","title":"Dbv Technologies盘中异动 股价大涨6.44%报0.703美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472644891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472644891?lang=zh_cn&edition=full","pubTime":"2024-10-04 01:23","pubTimestamp":1727976212,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日01时23分，Dbv Technologies股票出现波动，股价快速拉升6.44%。截至发稿，该股报0.703美元/股，成交量1.795万股，换手率0.02%，振幅2.15%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为1.50%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410040123339719e3aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410040123339719e3aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","BK4183","BK4139","DBVT"],"gpt_icon":0},{"id":"2472279545","title":"Dbv Technologies盘中异动 早盘急速下跌5.27%报0.692美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472279545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472279545?lang=zh_cn&edition=full","pubTime":"2024-10-02 22:59","pubTimestamp":1727881155,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日22时59分，Dbv Technologies股票出现波动，股价快速跳水5.27%。截至发稿，该股报0.692美元/股，成交量1.1081万股，换手率0.01%，振幅1.11%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为1.19%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002225915ab67780b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002225915ab67780b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2472375927","title":"Dbv Technologies盘中异动 早盘股价大涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472375927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472375927?lang=zh_cn&edition=full","pubTime":"2024-10-01 21:31","pubTimestamp":1727789467,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日21时31分，Dbv Technologies股票出现异动，股价急速拉升5.71%。截至发稿，该股报0.740美元/股，成交量6707股，换手率0.01%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.26%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012131109719dab6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410012131109719dab6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dbvtechnologies.com","stockEarnings":[{"period":"1week","weight":-0.1262},{"period":"1month","weight":-0.1574},{"period":"3month","weight":-0.3675},{"period":"6month","weight":-0.4946},{"period":"1year","weight":-0.6555},{"period":"ytd","weight":-0.6905}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"DBV Technologies S.A.是一家临床阶段专业生物制药公司，该公司专注于通过开发一个名为Viaskin的新的技术平台来改变免疫疗法领域。该公司的治疗方法是基于表皮免疫疗法（EPIT），该公司运用Viaskin新技术平台通过皮肤用专有的方法向免疫系统递送生物活性化合物。该公司是根据法兰西共和国法律注册成立于2002年3月29日。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.023953},{"month":2,"riseRate":0.5,"avgChangeRate":-0.00411},{"month":3,"riseRate":0.5,"avgChangeRate":0.002853},{"month":4,"riseRate":0.6,"avgChangeRate":0.072361},{"month":5,"riseRate":0.3,"avgChangeRate":-0.01824},{"month":6,"riseRate":0.3,"avgChangeRate":0.029895},{"month":7,"riseRate":0.5,"avgChangeRate":0.073589},{"month":8,"riseRate":0.3,"avgChangeRate":-0.04708},{"month":9,"riseRate":0.2,"avgChangeRate":-0.097377},{"month":10,"riseRate":0.1,"avgChangeRate":-0.171829},{"month":11,"riseRate":0.454545,"avgChangeRate":0.004434},{"month":12,"riseRate":0.7,"avgChangeRate":-0.003851}],"exchange":"NASDAQ","name":"DBV Technologies S.A.","nameEN":"DBV Technologies SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"DBV Technologies S.A.,DBVT,DBV Technologies S.A.股票,DBV Technologies S.A.股票老虎,DBV Technologies S.A.股票老虎国际,DBV Technologies S.A.行情,DBV Technologies S.A.股票行情,DBV Technologies S.A.股价,DBV Technologies S.A.股市,DBV Technologies S.A.股票价格,DBV Technologies S.A.股票交易,DBV Technologies S.A.股票购买,DBV Technologies S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}